Picture Berlin Partner HealthCapital Bionnale 2018 June Matchmaking 600x60px
Document › Details

Waters Corporation. (12/9/13). "Press Release: Waters Corporation Announces Transition Plans for Chief Financial Officer". Milford, MA.

Organisation Organisation Waters Corporation (NYSE: WAT)
  Group Waters (Group)
Products Product analytical instrument
  Product 2 reagents (bio/biochemical)
Persons Person Ornell, John (Bruker 201508– Board Director before Waters 2001–2013 CFO RETIRED 2014)
  Person 2 Cassis, Eugene G. (Gene) (Waters 201506 CFO before VP Investor Relations + VP Worldwide Business Development)

Waters Corporation (NYSE:WAT) today announced that John Ornell, its Chief Financial Officer, has communicated his intention to transition to a reduced workload and resign as the Company's Chief Financial Officer effective February 1, 2014. Mr. Ornell will then continue to serve the Company in an advisory capacity on a part-time basis. The Board of Directors of the Company has elected Eugene G. Cassis, who currently serves as Corporate Vice President of Worldwide Business Development and Investor Relations, to serve as the Company's interim Chief Financial Officer effective February 1, 2014.

Mr. Cassis has been with Waters Corporation for 33 years and has an extensive background in many financial, operational and technical areas of the company. In addition to his significant experience in business development and investor relations, Gene has held several senior positions within Waters including President of Nihon Waters K.K., Tokyo, Japan and Liquid Chromatography - Mass Spectrometry (LC-MS) Business Unit Manager.

Douglas A. Berthiaume, Chairman and Chief Executive Officer added: "I'd like to thank John for his dedication to Waters over the past 23 years and for his many contributions as the Company's CFO for the past 12 years. I am pleased that Gene Cassis will serve the Company as interim CFO. Gene brings a wealth of relevant experience and a record of success in key leadership positions while already enjoying close working relationships with our investor base, our banking contacts and with Waters Executive Committee."

About Waters Corporation:

For over 50 years, Waters Corporation (NYSE/WAT) has created business advantages for laboratory-dependent organizations by delivering practical and sustainable innovation to enable significant advancements in such areas as healthcare delivery, environmental management, food safety, and water quality worldwide.

Pioneering a connected portfolio of separations science, laboratory information management, mass spectrometry and thermal analysis, Waters technology breakthroughs and laboratory solutions provide an enduring platform for customer success.

With revenue of $1.84 billion in 2012, Waters is driving scientific discovery and operational excellence for customers worldwide.

Waters Corporation
Gene Cassis, 508-482-2349
V.P. Investor Relations

Record changed: 2016-03-19


Picture Fairtec GmbH Worldwide Event Solutions 600x60px

More documents for Waters (Group)

To subscribe to our free, monthly mass spectrometry newsletter, please send an e-mail to and simply fill the subject line with the word »MSC newsletter«

To get even more information, please take a look at our [gs] professional services offering and read the gene-sensor Product Flyer [PDF file]

Please visit also our web portals for the Eurpean life sciences and the life sciences in German-speaking Europe (DE, AT & CH) at and


Picture [LSE] – The Business Web Portal 600x80px

» top


Picture [iito] Twitter iitoLifeScience Life Sciences Mass Spec 120x120px Picture Berlin Partner HealthCapital Bionnale 2018 Germany June 120x240px Picture [LSE] – The Business Web Portal 120x600px Banner Fairtec GmbH Solutions for Smarter Business Events Exhibitions 120x120px Picture [iito] Twitter iitoLifeScience Life Sciences Mass Spec 120x120px Picture Berlin Partner HealthCapital Bionnale 2018 June Matchmaking 120x240px